These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 17292836)
1. Structure of the oncoprotein gankyrin in complex with S6 ATPase of the 26S proteasome. Nakamura Y; Nakano K; Umehara T; Kimura M; Hayashizaki Y; Tanaka A; Horikoshi M; Padmanabhan B; Yokoyama S Structure; 2007 Feb; 15(2):179-89. PubMed ID: 17292836 [TBL] [Abstract][Full Text] [Related]
2. Structural basis for the recognition between the regulatory particles Nas6 and Rpt3 of the yeast 26S proteasome. Nakamura Y; Umehara T; Tanaka A; Horikoshi M; Padmanabhan B; Yokoyama S Biochem Biophys Res Commun; 2007 Aug; 359(3):503-9. PubMed ID: 17555716 [TBL] [Abstract][Full Text] [Related]
3. Gankyrin: a new oncoprotein and regulator of pRb and p53. Dawson S; Higashitsuji H; Wilkinson AJ; Fujita J; Mayer RJ Trends Cell Biol; 2006 May; 16(5):229-33. PubMed ID: 16581249 [TBL] [Abstract][Full Text] [Related]
4. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Higashitsuji H; Itoh K; Nagao T; Dawson S; Nonoguchi K; Kido T; Mayer RJ; Arii S; Fujita J Nat Med; 2000 Jan; 6(1):96-9. PubMed ID: 10613832 [TBL] [Abstract][Full Text] [Related]
5. Solution structure of the human oncogenic protein gankyrin containing seven ankyrin repeats and analysis of its structure--function relationship. Yuan C; Li J; Mahajan A; Poi MJ; Byeon IJ; Tsai MD Biochemistry; 2004 Sep; 43(38):12152-61. PubMed ID: 15379554 [TBL] [Abstract][Full Text] [Related]
6. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Higashitsuji H; Higashitsuji H; Itoh K; Sakurai T; Nagao T; Sumitomo Y; Masuda T; Dawson S; Shimada Y; Mayer RJ; Fujita J Cancer Cell; 2005 Jul; 8(1):75-87. PubMed ID: 16023600 [TBL] [Abstract][Full Text] [Related]
7. The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53. Krzywda S; Brzozowski AM; Higashitsuji H; Fujita J; Welchman R; Dawson S; Mayer RJ; Wilkinson AJ J Biol Chem; 2004 Jan; 279(2):1541-5. PubMed ID: 14573599 [TBL] [Abstract][Full Text] [Related]
8. Gankyrin, the 26 S proteasome, the cell cycle and cancer. Mayer RJ; Fujita J Biochem Soc Trans; 2006 Nov; 34(Pt 5):746-8. PubMed ID: 17052188 [TBL] [Abstract][Full Text] [Related]
9. The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation. Higashitsuji H; Liu Y; Mayer RJ; Fujita J Cell Cycle; 2005 Oct; 4(10):1335-7. PubMed ID: 16177571 [TBL] [Abstract][Full Text] [Related]
10. Crystallization of gankyrin, an oncoprotein that interacts with CDK4 and the S6b (rpt3) ATPase of the 19S regulator of the 26S proteasome. Krzywda S; Brzozowski AM; Al-Safty R; Welchman R; Mee M; Dawson S; Fujita J; Higashitsuji H; Mayer RJ; Wilkinson AJ Acta Crystallogr D Biol Crystallogr; 2003 Jul; 59(Pt 7):1294-5. PubMed ID: 12832791 [TBL] [Abstract][Full Text] [Related]
11. Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26 S proteasome. Dawson S; Apcher S; Mee M; Higashitsuji H; Baker R; Uhle S; Dubiel W; Fujita J; Mayer RJ J Biol Chem; 2002 Mar; 277(13):10893-902. PubMed ID: 11779854 [TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the homolog of the oncoprotein gankyrin, an interactor of Rb and CDK4/6. Padmanabhan B; Adachi N; Kataoka K; Horikoshi M J Biol Chem; 2004 Jan; 279(2):1546-52. PubMed ID: 14583612 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the binding interaction between the oncoprotein gankyrin and a grafted S6 ATPase. Chapman AM; Rogers BE; McNaughton BR Biochemistry; 2014 Nov; 53(44):6857-9. PubMed ID: 25343477 [TBL] [Abstract][Full Text] [Related]
15. X-ray structure of human gankyrin, the product of a gene linked to hepatocellular carcinoma. Manjasetty BA; Quedenau C; Sievert V; Büssow K; Niesen F; Delbrück H; Heinemann U Proteins; 2004 Apr; 55(1):214-7. PubMed ID: 14997555 [No Abstract] [Full Text] [Related]
16. Discovery of multiple interacting partners of gankyrin, a proteasomal chaperone and an oncoprotein--evidence for a common hot spot site at the interface and its functional relevance. Nanaware PP; Ramteke MP; Somavarapu AK; Venkatraman P Proteins; 2014 Jul; 82(7):1283-300. PubMed ID: 24338975 [TBL] [Abstract][Full Text] [Related]
17. Synthetic Proteins Potently and Selectively Bind the Oncoprotein Gankyrin, Modulate Its Interaction with S6 ATPase, and Suppress Gankyrin/MDM2-Dependent Ubiquitination of p53. Chapman AM; McNaughton BR ACS Chem Biol; 2015 Aug; 10(8):1880-6. PubMed ID: 25955581 [TBL] [Abstract][Full Text] [Related]
18. Oncoprotein p28 GANK binds to RelA and retains NF-kappaB in the cytoplasm through nuclear export. Chen Y; Li HH; Fu J; Wang XF; Ren YB; Dong LW; Tang SH; Liu SQ; Wu MC; Wang HY Cell Res; 2007 Dec; 17(12):1020-9. PubMed ID: 18040287 [TBL] [Abstract][Full Text] [Related]
19. Quaternary structure of the ATPase complex of human 26S proteasomes determined by chemical cross-linking. Hartmann-Petersen R; Tanaka K; Hendil KB Arch Biochem Biophys; 2001 Feb; 386(1):89-94. PubMed ID: 11361004 [TBL] [Abstract][Full Text] [Related]
20. Prediction of a common structural scaffold for proteasome lid, COP9-signalosome and eIF3 complexes. Scheel H; Hofmann K BMC Bioinformatics; 2005 Mar; 6():71. PubMed ID: 15790418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]